Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Congenital Venous Malformation
Interventions
DRUG

Ethanol 96% Gel

DRUG

Ethanol 98% Solution

Trial Locations (2)

21287

Johns Hopkins Medical Institutions, Baltimore

37044

Hôpital Bretonneau Service de neuroradiologie, Tours

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

FDA Office of Orphan Products Development

FED

lead

Orfagen

INDUSTRY